Back to search

Czechia· CZ-0274001

MAGNESIUM PHOSPHORICUM ADLER PHARMA

A v12 product containing magnesii hydrogenophosphas 6 d, registered in Czechia by Adler Pharma Produktion und Vertrieb GmbH, Zell am See.

ATC V12

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedMAGNESIUM PHOSPHORICUM ADLER PHARMAATCV12REGISTER NO.CZ-0274001PACKS LISTED0CHECKEDSeptember 28, 2026

The record

At a glance

SÚKL (Czech Republic)
Active substance
MAGNESII HYDROGENOPHOSPHAS 6 D
Manufacturer
Adler Pharma Produktion und Vertrieb GmbH, Zell am See
Country
Czechia (CZ)
ATC code
V12
ATC class
V12
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/288f6fc8-3c3b-43bf-9559-045f4f116ec6
GET /v1/drugs/288f6fc8-3c3b-43bf-9559-045f4f116ec6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "TBL NOB",
  "source": "sukl",
  "strength": "D6",
  "pack_size": "400",
  "substance": "MAGNESII HYDROGENOPHOSPHAS 6 D",
  "cz_kod_sukl": "0274001",
  "product_type": "HO",
  "substance_codes": "50795",
  "registration_state": "R",
  "registration_number": "93/040/23-C"
}

See everything about magnesii hydrogenophosphas 6 d.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.